Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.

Arch Immunol Ther Exp (Warsz) · 2016 · PMC4805698 · PMID 26084760

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP > 0.10so close (0.05 < p ≤ 0.1)

The main obstacle to interpret our survival data is the low number of EBV-positive cases, as well as slightly uneven distribution of rituximab therapy in EBV-positive and EBV-negative cases (this heterogeneity did not reach statistical significance: 33 vs 71 %, respectively; P > 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.